Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value ($000): $265,477 (100.0% shares, 0.0% debt)

Holdings (28)

Value ($000) $25,692 Shares 530,050 Est. Cost $47.34 Unrealized —

— CURIS INC 9.1%

Value ($000) $24,093 Shares 2,128,400 Est. Cost $8.19 Unrealized —

APLS APELLIS PHARMACEUTICALS INC 8.9%

Value ($000) $23,531 Shares 548,374 Est. Cost $42.30 Unrealized +11.9%

FDMT 4D MOLECULAR THERAPEUTICS IN 6.2%

Value ($000) $16,410 Shares 378,288 Est. Cost $41.28 Unrealized +7.3%

— ACCELERON PHARMA INC 5.7%

Value ($000) $15,238 Shares 112,363 Est. Cost $127.94 Unrealized —

GOSS GOSSAMER BIO INC 4.9%

Value ($000) $13,072 Shares 1,413,138 Est. Cost $9.85 Unrealized +2.4%

ARVN ARVINAS INC 4.4%

Value ($000) $11,799 Shares 178,500 Est. Cost $34.48 Unrealized +121.8%

CLDX CELLDEX THERAPEUTICS INC NEW 4.4%

Value ($000) $11,565 Shares 561,398 Est. Cost $18.00 Unrealized +27.6%

— IKENA ONCOLOGY INC 4.3%

Value ($000) $11,300 Shares 400,000 Est. Cost $28.25 Unrealized —

RCUS ARCUS BIOSCIENCES INC 4.2%

Value ($000) $11,232 Shares 400,000 Est. Cost $26.85 Unrealized +29.6%

RNAM AVIDITY BIOSCIENCES INC 3.7%

Value ($000) $9,741 Shares 446,641 Est. Cost $28.99 Unrealized -15.5%

DYN DYNE THERAPEUTICS INC 3.4%

Value ($000) $9,064 Shares 583,649 Est. Cost $19.71 Unrealized -1.8%

PMVP PMV PHARMACEUTICALS INC 3.1%

Value ($000) $8,223 Shares 250,000 Est. Cost $39.23 Unrealized +0.5%

— CHEMOCENTRYX INC 2.9%

Value ($000) $7,690 Shares 150,076 Est. Cost $61.92 Unrealized —

DSGN DESIGN THERAPEUTICS INC 2.8%

Value ($000) $7,475 Shares 250,000 Est. Cost $31.14 Unrealized 0.0%

— CONNECT BIOPHARMA HLDGS LTD 2.6%

Value ($000) $6,910 Shares 373,492 Est. Cost $18.50 Unrealized —

TSHA TAYSHA GENE THERAPIES INC 2.5%

Value ($000) $6,505 Shares 320,440 Est. Cost $21.54 Unrealized +25.7%

CRDF CARDIFF ONCOLOGY INC 2.3%

Value ($000) $6,019 Shares 650,000 Est. Cost $17.58 Unrealized -30.9%

— NGM BIOPHARMACEUTICALS INC 2.2%

Value ($000) $5,814 Shares 200,000 Est. Cost $29.53 Unrealized —

RVMD REVOLUTION MEDICINES INC 2.2%

Value ($000) $5,787 Shares 126,136 Est. Cost $39.54 Unrealized +13.4%

— KRONOS BIO INC 1.6%

Value ($000) $4,278 Shares 146,173 Est. Cost $29.87 Unrealized —

— IVERIC BIO INC 1.6%

Value ($000) $4,203 Shares 680,036 Est. Cost $6.91 Unrealized —

— MERUS N V 1.6%

Value ($000) $4,178 Shares 200,000 Est. Cost $20.89 Unrealized —

MLTX HELIX ACQUISITION CORP 1.5%

Value ($000) $4,080 Shares 400,000 Est. Cost $11.37 Unrealized —

EWTX EDGEWISE THERAPEUTICS INC 1.5%

Value ($000) $4,063 Shares 125,000 Est. Cost $32.43 Unrealized 0.0%

— PROMETHEUS BIOSCIENCES INC 1.4%

Value ($000) $3,652 Shares 200,000 Est. Cost $18.26 Unrealized —

— JIYA ACQUISITION CORP 1.1%

Value ($000) $2,952 Shares 300,000 Est. Cost $10.30 Unrealized —

FHTX FOGHORN THERAPEUTICS INC 0.3%

Value ($000) $911 Shares 69,132 Est. Cost $16.39 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NBP	I MAB	530,050	$25,692	9.7%	$47.34	—	SPONSORED ADS	44975P103
—	CURIS INC	2,128,400	$24,093	9.1%	$8.19	—	COM NEW	231269200
APLS	APELLIS PHARMACEUTICALS INC	548,374	$23,531	8.9%	$42.30	+11.9%	COM	03753U106
FDMT	4D MOLECULAR THERAPEUTICS IN	378,288	$16,410	6.2%	$41.28	+7.3%	COM	35104E100
—	ACCELERON PHARMA INC	112,363	$15,238	5.7%	$127.94	—	COM	00434H108
GOSS	GOSSAMER BIO INC	1,413,138	$13,072	4.9%	$9.85	+2.4%	COM	38341P102
ARVN	ARVINAS INC	178,500	$11,799	4.4%	$34.48	+121.8%	COM	04335A105
CLDX	CELLDEX THERAPEUTICS INC NEW	561,398	$11,565	4.4%	$18.00	+27.6%	COM NEW	15117B202
—	IKENA ONCOLOGY INC	400,000	$11,300	4.3%	$28.25	—	COM	45175G108
RCUS	ARCUS BIOSCIENCES INC	400,000	$11,232	4.2%	$26.85	+29.6%	COM	03969F109
RNAM	AVIDITY BIOSCIENCES INC	446,641	$9,741	3.7%	$28.99	-15.5%	COM	05370A108
DYN	DYNE THERAPEUTICS INC	583,649	$9,064	3.4%	$19.71	-1.8%	COM	26818M108
PMVP	PMV PHARMACEUTICALS INC	250,000	$8,223	3.1%	$39.23	+0.5%	COM	69353Y103
—	CHEMOCENTRYX INC	150,076	$7,690	2.9%	$61.92	—	COM	16383L106
DSGN	DESIGN THERAPEUTICS INC	250,000	$7,475	2.8%	$31.14	0.0%	COM	25056L103
—	CONNECT BIOPHARMA HLDGS LTD	373,492	$6,910	2.6%	$18.50	—	ADS	207523101
TSHA	TAYSHA GENE THERAPIES INC	320,440	$6,505	2.5%	$21.54	+25.7%	COM SHS	877619106
CRDF	CARDIFF ONCOLOGY INC	650,000	$6,019	2.3%	$17.58	-30.9%	COM	14147L108
—	NGM BIOPHARMACEUTICALS INC	200,000	$5,814	2.2%	$29.53	—	COM	62921N105
RVMD	REVOLUTION MEDICINES INC	126,136	$5,787	2.2%	$39.54	+13.4%	COM	76155X100
—	KRONOS BIO INC	146,173	$4,278	1.6%	$29.87	—	COM	50107A104
—	IVERIC BIO INC	680,036	$4,203	1.6%	$6.91	—	COM	46583P102
—	MERUS N V	200,000	$4,178	1.6%	$20.89	—	COM	N5749R100
MLTX	HELIX ACQUISITION CORP	400,000	$4,080	1.5%	$11.37	—	COM CL A	G4444C102
EWTX	EDGEWISE THERAPEUTICS INC	125,000	$4,063	1.5%	$32.43	0.0%	COM	28036F105
—	PROMETHEUS BIOSCIENCES INC	200,000	$3,652	1.4%	$18.26	—	COM	74349U108
—	JIYA ACQUISITION CORP	300,000	$2,952	1.1%	$10.30	—	COM CL A	47760M102
FHTX	FOGHORN THERAPEUTICS INC	69,132	$911	0.3%	$16.39	0.0%	COM	344174107